Trial drug helps rectal cancer patients avoid surgery
Paul Cusick is part of the PRIME RT trial, investigating the combination of immunotherapy, chemotherapy and radiotherapy Read More
Paul Cusick is part of the PRIME RT trial, investigating the combination of immunotherapy, chemotherapy and radiotherapy Read More
We speak to Dr Fabio Gomes about never smokers and the ALK positive mutation in Non-Small Cell Lung Cancer (NSCLC). Read More
Over the next two months, Macarena, Nadin and Hadiyat will return to their medical studies while also writing up their theses aiming to graduate with MBChB and PhD in 2025 or 2026. Read More
Manchester researchers have developed a way to improve the accuracy of breast cancer genetic testing for women from Ashkenazi Jewish backgrounds. Read More
We speak to Professor Caroline Dive about cancer biomarkers and how liquid biopsies could pave the way for lung cancer detection and treatment. Read More
On Friday 30th June, Manchester Breast Centre (MBC) hosted a Festschrift Meeting at the Oglesby Cancer Research Building to celebrate Professor Tony Howell’s academic achievements. Read More
June has been eventful at the MCRC with events to mark our postgraduate researchers, celebrating the lifetime work of Prof. Juan Valle, presenting research at international conferences as well as forging ahead with new research projects and alliances. Read More
From 12th to 16th May 2023, representatives from the MCRC attended ESTRO 2023 in Austria, Vienna, alongside many esteemed radiotherapy colleagues for Europe’s largest industry exhibition in radiation oncology. Read More
A pioneering cancer research project launched in memory of singer Sarah Harding has recruited its first participant. Read More
She’s undertaking a Non-Clinical PhD, funded through the MCRC-CRUK Manchester Centre PhD training scheme. The aim of her PhD is to investigate how radiotherapy affects immune cells and their ability to fight off cancer cells in the body. Read More
University of Manchester Innovation Factory Ltd is the University’s agent for commercialisation and drives technology transfer for the University. Their mission is to use the Intellectual Property (IP) developed at The University of Manchester to create positive social, economic and environmental impact. Read more about how to commercialise your research in this blog. Read More
She’s doing a clinical research training fellowship, funded by Cancer Research UK. Her PhD project is looking at the genetic patterns of lung cancer KRAS mutations to help identify alternative treatment options. Read More
We speak to Dr Colin Lindsay about the basic biology of lung cancer with Dr Colin Lindsay: Exploring oncogenic drivers such as the KRAS mutation Read More
At present, 14% of those diagnosed with lung cancer are ''never-smokers”. In other words, they have smoked fewer than 100 cigarettes in their life. So, how is it that we’ve come to assume that smoking alone causes lung cancer? Read More